Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in GH — Guardant Health, Inc.

CIK 1323645 PARIS, I0

Position in GH

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$1,412,799
-$1,860,358 QoQ
Shares Held
15,295
-85.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Mar 31, 2024
CallValue
$418,789
CallShares
20,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $150,158,879 across 8 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,412,799 15,295
2024-12-31 $3,273,157 107,141
2024-09-30 $3,936,091 171,582
2024-06-30 $5,146,964 178,219
2024-03-31 $6,437,199 312,031
2024-03-31 $418,789 20,300
2023-12-31 $1,993,585 73,700
2023-12-31 $973,800 36,000
2023-12-31 $5,635,299 208,329
2023-09-30 $311,220 10,500
2023-09-30 $6,545,164 220,822
2023-06-30 $8,463,406 236,408
2023-06-30 $372,320 10,400
2023-03-31 $5,350,953 228,283
2022-12-31 $3,312,796 121,794
2021-12-31 $1,591,018 15,907
2021-09-30 $2,212,677 17,700
2021-03-31 $1,557,030 10,200
2020-03-31 $508,915 7,312
2020-03-31 $229,680 3,300